Brainstorm Cell Therapeutics (BCLI) Institutional Ownership $1.18 -0.06 (-4.84%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.15 -0.03 (-2.54%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Brainstorm Cell Therapeutics (NASDAQ:BCLI)CurrentInstitutional OwnershipPercentage14.33%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$41.07MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.67M Get BCLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCLI Institutional Buying and Selling by Quarter Brainstorm Cell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025 Armistice Capital LLC690,666$870K0.0%N/A10.590% 2/14/2025 Two Sigma Securities LLC11,300$26K0.0%-42.9%0.198% 2/12/2025 Geode Capital Management LLC52,501$119K0.0%-92.3%0.921% 2/10/2025 Liberty Wealth Management LLC22,666$51K0.0%-93.3%0.397% 1/8/2025 Weaver Consulting Group15,623$35K0.0%-93.3%0.274% 8/15/2024 Armistice Capital LLC7,917,653$2.68M0.0%N/A11.298% 4/15/2024 Kingswood Wealth Advisors LLC81,050$46K0.0%N/A0.119% 8/14/2023 Mirador Capital Partners LP25,084$52K0.0%N/A0.064% 8/9/2023 Kingswood Wealth Advisors LLC16,600$34K0.0%N/A0.042% 7/31/2023 Socha Financial Group LLC12,380$26K0.0%N/A0.031% Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/26/2023 Janney Montgomery Scott LLC20,000$41K0.0%N/A0.051% 7/12/2023 Professional Financial Advisors LLC17,279$36K0.0%N/A0.044% 5/15/2023 AIGH Capital Management LLC1,459,095$4.82M1.8%N/A3.978% 5/10/2023 Nelson Van Denburg & Campbell Wealth Management Group LLC12,686$42K0.0%N/A0.035% 5/3/2023 Liberty Wealth Management LLC150,400$496K0.1%N/A0.410% 4/26/2023 TRU Independence Asset Management 2 LLC44,000$145K0.1%N/A0.120% 4/14/2023Raymond James Financial Services Advisors Inc.11,248$37K0.0%N/A0.031% 4/14/2023Raymond James & Associates164,703$544K0.0%-22.6%0.449% 11/15/2022 Liberty Wealth Management LLC40,000$176K0.0%+33.3%0.110% 11/14/2022 Boothbay Fund Management LLC19,098$84K0.0%-31.5%0.052% 11/8/2022 IFP Advisors Inc28,850$151K0.0%+45.3%0.079% 11/3/2022 Creative Planning30,681$136K0.0%N/A0.084% 10/31/2022 TRU Independence Asset Management 2 LLC44,000$194K0.2%N/A0.121% 10/25/2022 Janney Montgomery Scott LLC20,000$88K0.0%N/A0.055% 10/25/2022Raymond James & Associates244,803$1.08M0.0%+30.6%0.671% 10/20/2022 Jmac Enterprises LLC40,430$179K0.1%-11.0%0.111% 10/6/2022 Abner Herrman & Brock LLC280,000$1.24M0.2%+5.7%0.767% 8/12/2022 Ikarian Capital LLC253,432$698K0.1%-16.7%0.695% 7/20/2022 Weaver Consulting Group104,653$289K0.2%-19.5%0.287% 7/11/2022S.C. Financial Services Inc.25,471$70K0.1%+66.6%0.070% 5/6/2022 Weaver Consulting Group130,000$437K0.2%-16.4%0.356% 4/7/2022 Abner Herrman & Brock LLC265,000$890K0.1%+13.7%0.726% 2/9/2022 Geneos Wealth Management Inc.10,100$40K0.0%N/A0.028% 2/8/2022 Steward Partners Investment Advisory LLC9,700$39K0.0%-42.9%0.027% 2/8/2022Raymond James & Associates189,503$758K0.0%-11.4%0.522% 2/2/2022 Aptus Capital Advisors LLC12,500$50K0.0%-21.9%0.034% 2/1/2022 Weaver Consulting Group155,500$622K0.3%+201.9%0.429% 1/26/2022S.C. Financial Services Inc.15,285$52K0.1%N/A0.042% 1/13/2022 Abner Herrman & Brock LLC233,000$932K0.1%+13.7%0.642% 11/15/2021 GSA Capital Partners LLP172,056$568K0.1%+185.6%0.474% A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.11/9/2021BlackRock Inc.468,967$1.55M0.0%-1.1%1.293% 10/6/2021 Abner Herrman & Brock LLC205,000$676K0.1%-15.1%0.564% 8/17/2021 Millennium Management LLC371,460$1.41M0.0%N/A1.023% 8/17/2021 Price T Rowe Associates Inc. MD93,000$353K0.0%-23.9%0.256% 8/16/2021 LMR Partners LLP11,735$45K0.0%N/A0.032% 8/16/2021 Charles Schwab Investment Management Inc.11,287$43K0.0%-85.6%0.031% 8/16/2021 State Street Corp86,703$329K0.0%-83.2%0.239% 8/16/2021Tibra Equities Europe Ltd87,000$331K0.1%N/A0.240% 8/16/2021 Goldman Sachs Group Inc.57,679$220K0.0%+144.4%0.159% 8/13/2021 Renaissance Technologies LLC47,600$181K0.0%N/A0.131% 8/13/2021 Steward Partners Investment Advisory LLC19,000$72K0.0%-38.3%0.052% 8/13/2021 Northern Trust Corp49,761$189K0.0%-83.4%0.137% 8/13/2021 Geode Capital Management LLC265,138$1.01M0.0%-44.6%0.730% 8/13/2021 Vanguard Group Inc.1,412,826$5.37M0.0%+6.2%3.890% 8/12/2021 JPMorgan Chase & Co.698,294$2.65M0.0%-13.3%1.923% 8/12/2021Ergoteles LLC124,329$472K0.0%N/A0.342% 8/11/2021 Bank of New York Mellon Corp15,899$61K0.0%-82.1%0.044% 8/11/2021BlackRock Inc.474,347$1.80M0.0%-75.7%1.306% 8/5/2021 GSA Capital Partners LLP60,238$229K0.0%+137.7%0.166% 8/2/2021 Advisor Group Holdings Inc.10,920$42K0.0%-54.5%0.030% 6/5/2021 Advisory Services Network LLC10,000$38K0.0%N/A0.028% 5/18/2021 Voloridge Investment Management LLC87,393$335K0.0%-75.6%0.241% 5/18/2021 Cubist Systematic Strategies LLC10,992$42K0.0%N/A0.030% 5/18/2021 IHT Wealth Management LLC10,000$38K0.0%-23.1%0.028% 5/17/2021 Schonfeld Strategic Advisors LLC12,400$48K0.0%-36.4%0.034% 5/17/2021 Price T Rowe Associates Inc. MD122,161$468K0.0%+460.2%0.336% 5/17/2021 Ikarian Capital LLC293,200$1.12M0.0%N/A0.807% 5/17/2021 Goldman Sachs Group Inc.23,604$90K0.0%-23.4%0.065% 5/13/2021 Barclays PLC25,500$98K0.0%+193.4%0.070% 5/12/2021 Northern Trust Corp299,433$1.15M0.0%-1.7%0.824% 5/12/2021 Geode Capital Management LLC478,258$1.83M0.0%+17.8%1.317% 5/12/2021 JPMorgan Chase & Co.805,438$3.09M0.0%+105.3%2.218% 5/12/2021 UBS Group AG16,298$63K0.0%+43.9%0.045% 5/11/2021 New York State Common Retirement Fund15,000$57K0.0%+163.2%0.041% 5/10/2021 HighTower Advisors LLC10,516$40K0.0%N/A0.029% 5/10/2021 GSA Capital Partners LLP25,344$97K0.0%N/A0.070% 5/10/2021 Phoenix Holdings Ltd.56,821$214K0.0%-67.3%0.156% 5/7/2021BlackRock Inc.1,953,247$7.48M0.0%+1.7%5.378% 5/6/2021 Aptus Capital Advisors LLC16,050$61K0.0%-53.0%0.044% 5/6/2021 Alliancebernstein L.P.23,000$88K0.0%-22.6%0.063% (Data available from 1/1/2016 forward) BCLI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCLI shares? During the previous two years, 10 institutional investors and hedge funds held shares of Brainstorm Cell Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($870K), Geode Capital Management LLC ($119K), Mirador Capital Partners LP ($52K), Liberty Wealth Management LLC ($51K), Kingswood Wealth Advisors LLC ($46K), Janney Montgomery Scott LLC ($41K), and Professional Financial Advisors LLC ($36K).Learn more on BCLI's institutional investors. What percentage of Brainstorm Cell Therapeutics stock is owned by institutional investors? 14.33% of Brainstorm Cell Therapeutics stock is owned by institutional investors. Learn more on BCLI's institutional investor holdings. Which institutional investors have been buying Brainstorm Cell Therapeutics stock? The following institutional investors have purchased Brainstorm Cell Therapeutics stock in the last 24 months: Armistice Capital LLC ($8.61M), Kingswood Wealth Advisors LLC ($97.65K), Mirador Capital Partners LP ($25.08K), Janney Montgomery Scott LLC ($20K), Professional Financial Advisors LLC ($17.28K), and Socha Financial Group LLC ($12.38K). How much institutional buying is happening at Brainstorm Cell Therapeutics? Institutional investors have bought a total of 8,780,712 shares in the last 24 months. This purchase volume represents approximately $44.58M in transactions. Which Brainstorm Cell Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Brainstorm Cell Therapeutics stock in the last 24 months: Geode Capital Management LLC ($630.32K), Liberty Wealth Management LLC ($317.48K), Weaver Consulting Group ($218.73K), and Two Sigma Securities LLC ($8.50K). How much institutional selling is happening at Brainstorm Cell Therapeutics? Institutional investors have sold a total of 1,175,028 shares in the last 24 months. This volume of shares sold represents approximately $2.67M in transactions. Related Companies KZR Institutional Ownership FGEN Institutional Ownership MRNS Institutional Ownership INKT Institutional Ownership ALLK Institutional Ownership SCLX Institutional Ownership CALC Institutional Ownership GRCE Institutional Ownership SRZN Institutional Ownership OKUR Institutional Ownership This page (NASDAQ:BCLI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCLI Stock Free BCLI Stock Alerts